Mobin Wan
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
- Liver physiology and pathology
- Epidemiology top 10%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 11
- Hepatitis B Virus Studies 11
- Liver Disease Diagnosis and Treatment 2
-
- Hepatitis C virus research 2
- Co-authors
- Chengzhong Li (4 shared papers)Xue-Song Liang (1 shared paper)Ying Zhou (1 shared paper)Demin Yu (1 shared paper)Li Chen (2 shared papers)Xinxin Zhang (1 shared paper)Qian Zhang (1 shared paper)Xia-qiu Zhou (4 shared papers)
- Journals
- Journal of Hepatology (2 papers)World Journal of Gastroenterology (2 papers)Advances in Therapy (1 paper)Hepatology International (1 paper)Liver International (1 paper)
- Partner nations
- ChinaSwitzerlandUnited States
In The Last Decade
Mobin Wan
14 papers receiving 360 citations
Peers
Comparison fields: 5 of 54
- Hepatology 164
- Epidemiology 238
- Immunology 46
- Infectious Diseases 29
- Pharmacology 13
Countries citing papers authored by Mobin Wan
This map shows the geographic impact of Mobin Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mobin Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mobin Wan more than expected).
Fields of papers citing papers by Mobin Wan
This network shows the impact of papers produced by Mobin Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mobin Wan. The network helps show where Mobin Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mobin Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 73 | |
| 2 | 2003 | 66 | |
| 3 | 2009 | 58 | |
| 4 | 2012 | 58 | |
| 5 | 2011 | 40 | |
| 6 | 2016 | 36 | |
| 7 | 2015 | 18 | |
| 8 | 2013 | 13 | |
| 9 | [The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52]. | 2007 | 3 |
| 10 | [A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients]. | 2006 | 3 |
| 11 | An expert consensus on the adjustment of treatment strategies in patients with chronic hepatitis B treated with non-firstline nucleos(t)ide analogues. | 2019 | 1 |
| 12 | Comparison and interpretation of chronic hepatitis B guidelines on the anti-virus treatment. | 2010 | 1 |
| 13 | [The study on frequency distribution of regulatory T cells and its functional markers in peripheral blood of chronic hepatitis B]. | 2011 | 1 |
| 14 | [Construction of X-gene defect HBV expression plasmid and cells transfection study]. | 2003 | 1 |
| 15 | 2010 | 0 |
About Mobin Wan
Mobin Wan is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Organic Chemistry and Surgery, having authored 15 papers that have together received 372 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (11 papers), Liver Disease Diagnosis and Treatment (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Hepatology (164 citations), Epidemiology (238 citations), Immunology (46 citations), Infectious Diseases (29 citations) and Pharmacology (13 citations). Mobin Wan has collaborated with scholars based in China, Switzerland and United States. Frequent co-authors include Chengzhong Li, Xue-Song Liang, Ying Zhou, Demin Yu, Li Chen, Xinxin Zhang, Qian Zhang, Xia-qiu Zhou, Shanming Wu and Jiqiang Li. Their work appears in journals such as Journal of Hepatology, World Journal of Gastroenterology, Advances in Therapy, Hepatology International and Liver International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.